MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Egalet Corp Company Profile (NASDAQ:EGLT)

Consensus Ratings for Egalet Corp (NASDAQ:EGLT) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $19.75 (315.79% upside)

Analysts' Ratings History for Egalet Corp (NASDAQ:EGLT)
Show:
DateFirmActionRatingPrice TargetActions
3/28/2016Cantor FitzgeraldReiterated RatingBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Janney Montgomery ScottInitiated CoverageNeutral$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2015GuggenheimReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015JMP SecuritiesBoost Price TargetOutperform$18.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2014Stifel NicolausLower Price TargetBuy$20.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Egalet Corp (NASDAQ:EGLT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q116($0.87)($0.76)$3.50 million$2.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.91)($0.28)$2.80 million$2.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.90)($0.81)$1.62 million$1.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($1.02)($0.98)$1.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015($0.98)($1.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/25/2015Q414($0.69)($0.48)$5.64 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q314($0.77)($0.63)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q214($0.42)($0.73)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114($0.16)($1.39)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Egalet Corp (NASDAQ:EGLT)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Egalet Corp (NASDAQ:EGLT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Egalet Corp (NASDAQ:EGLT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/5/2016Deanne F MelloyInsiderSell860$6.96$5,985.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/5/2016Robert S RadieCEOSell5,000$6.99$34,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Robert S RadieCEOSell10,000$6.97$69,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Robert S. RadieCEOSell10,000$9.65$96,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2016Robert S. RadieCEOSell5,000$10.52$52,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2015Deanne F MelloyInsiderSell860$11.42$9,821.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Robert S RadieCEOSell15,000$12.27$184,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Stan MusialCFOSell8,480$12.32$104,473.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2015Mark StrobeckInsiderSell5,220$12.56$65,563.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2015Robert S RadieCEOSell6,000$11.97$71,820.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015Robert S RadieCEOSell9,000$12.53$112,770.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Mark StrobeckInsiderSell10,440$12.98$135,511.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Stan MusialCFOSell8,480$13.20$111,936.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Robert S RadieCEOSell11,130$11.25$125,212.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Jeffrey M DaynoInsiderSell2,500$8.87$22,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Mark StrobeckInsiderSell3,480$5.09$17,713.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Robert S RadieCEOSell11,130$5.11$56,874.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Robert S RadieCEOSell40,040$9.61$384,784.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Robert S RadieCEOSell49,000$9.74$477,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Mark StrobeckInsiderSell5,135$9.20$47,242.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Mark StrobeckInsiderSell5,700$10.28$58,596.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Mark StrobeckInsiderSell3,085$11.50$35,477.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Stan MusialCFOSell13,920$11.05$153,816.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Jean Francois FormelaDirectorBuy41,667$12.00$500,004.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Life Science Ventures SunstoneMajor ShareholderBuy133,333$12.00$1,599,996.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Egalet Corp (NASDAQ:EGLT)
DateHeadline
06/24/16 10:34 AMShare Volatility Check for: Egalet Corporation (NASDAQ:EGLT) - Press Telegraph
06/23/16 06:43 AMEgalet Corporation (EGLT) Hits New 52-week Low During June 21 Session - Equities.com
06/23/16 06:43 AMEgalet Corporation (EGLT) Jumps 9.03% on June 22 - Equities.com
06/22/16 03:53 PMEgalet Corporation (NasdaqGM:EGLT) Stock Momentum Hits EXTREME Weakness - CML News
06/21/16 03:49 PMEGALET CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/17/16 03:37 PMEgalet Corporation (EGLT) Hits New 52-week Low During June 14 Session - Equities.com
06/17/16 07:46 AMEgalet Corp (EGLT) Current Analyst Ratings - Fiscal Standard
06/17/16 07:46 AMEgalet Corporation (EGLT) Hits New 52-week Low During June 15 Session - Equities.com
06/16/16 03:52 PMEGALET CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/13/16 03:29 PMData Presented at College on Problems of Drug Dependence (CPDD) Meeting Show Egalet's Guardian Technology Offers Both Strong Abuse-Deterrent Features and Precision Drug Delivery - [at noodls] - WAYNE, Pa., June 13, 2016/PRNewswire / -- Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain ...
06/10/16 05:09 AMEgalet President and CEO Bob Radie Named EY Entrepreneur of the Year® - [at noodls] - WAYNE, Penn., June 10, 2016/PRNewswire / -- Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain ...
06/07/16 09:27 PMEgalet Corporation (EGLT) Jumps 5.79% on June 06 - Equities.com
06/06/16 07:06 AMEgalet Corp (EGLT) Broker Price Targets For The Coming Week - Share Trading News
06/01/16 04:00 PMBuy, Sell Or Hold Rating For Egalet Corp (EGLT)? - Share Trading News - Buy, Sell Or Hold Rating For Egalet Corp (EGLT)?Share Trading NewsEgalet Corp has a 50 day moving average of 6.16 and a 200 day moving average of 7.86. The stock's market capitalization is 142.63M, it has a 52-week low of 4.96 and a 52-week high of 16.59. The share price of the company (EGLT) was up +1.96%, with a ...
06/01/16 08:14 AMEgalet Corp (EGLT) Jumps 6.59% on May 30 - Equities.com - Egalet Corp (EGLT) Jumps 6.59% on May 30Equities.comEgalet Corp (EGLT) was among the biggest gainers on the Russell 2000 for Monday May 30 as the stock popped 6.59% to $5.66, representing a gain of $0.35 per share. Some 73,533 shares traded hands on 593 trades, compared with an average daily ...and more »
05/28/16 10:39 AMEgalet Corp (EGLT) Jumps 6.59% on May 27 - Equities.com - Egalet Corp (EGLT) Jumps 6.59% on May 27Equities.comEgalet Corp (EGLT) was among the biggest gainers on the Russell 2000 for Friday May 27 as the stock popped 6.59% to $5.66, representing a gain of $0.35 per share. Some 73,533 shares traded hands on 593 trades, compared with an average daily volume ...and more »
05/26/16 10:47 AMEgalet Corp (EGLT) Updated Broker Price Targets - Share Trading News - Egalet Corp (EGLT) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Egalet Corp (EGLT). The latest reports which are currently in issue on Tuesday 24th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...Egalet Corporation (NASDAQ:EGLT) Shorts Decreased by 6.54% After Short CoveringWall Street Hints and Newsall 2 news articles »
05/23/16 08:10 AMEGALET CORP Files SEC form 8-K, Other Events -
05/23/16 05:06 AMEgalet Settles Patent Litigations with Purdue Pharma - [at noodls] - WAYNE, Pa., May 23, 2016/PRNewswire / -- Egalet Corporation (Nasdaq: EGLT) ('Egalet'), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative ...
05/20/16 10:46 AMETF’s with exposure to Egalet Corp. : May 20, 2016 -
05/19/16 12:04 PMEGALET CORP Financials -
05/17/16 01:35 PMEgalet Corp. :EGLT-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/12/16 07:17 AMEgalet Human Abuse Potential Data at American Pain Society Annual Meeting Demonstrates Significantly Lower Intranasal Abuse Potential of ARYMO™ ER Compared to MS Contin® - [at noodls] - WAYNE, Pa., May 12, 2016/PRNewswire / -- Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain ...
05/10/16 09:35 AMEGALET CORP Files SEC form 10-Q, Quarterly Report -
05/10/16 06:07 AMQ1 2016 Egalet Corp Earnings Release - Before Market Open -
05/10/16 05:22 AMEgalet reports 1Q loss -
05/10/16 05:08 AMEgalet Reports First Quarter 2016 Financial Results - [at noodls] - WAYNE, Pa., May 10, 2016/PRNewswire / -- Egalet Corporation (Nasdaq: EGLT) ('Egalet'), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative ...
05/05/16 05:21 AMEgalet Announces Scientific Presentations at American Pain Society Meeting - [at noodls] - WAYNE, Pa., May 5, 2016/PRNewswire / -- Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and ...
03/11/16 04:07 PMEGALET CORP Files SEC form 10-K, Annual Report -
03/08/16 06:07 AMQ4 2015 Egalet Corp Earnings Release - Before Market Open -
03/08/16 06:02 AMEGALET CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
03/08/16 05:20 AMEgalet reports 4Q loss -
03/08/16 05:00 AMEgalet Reports Fourth Quarter and Full Year 2015 Financial Results - [PR Newswire] - WAYNE, Pa., March 8, 2016 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing ...
02/29/16 05:00 AMEgalet Announces FDA Acceptance of New Drug Application for ARYMO™ ER (Morphine Sulfate) Extended-Release Tablets - [PR Newswire] - WAYNE, Pa., Feb. 29, 2016 /PRNewswire/ -- Egalet Corporation (EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for ARYMO ER (morphine sulfate) extended-release tablets. ARYMO ER is being developed for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The FDA Prescription Drug User Fee Act (PDUFA) goal date for a decision is October 14, 2016.
02/26/16 10:33 AMEgalet Corp (EGLT) Drops 5.32% on February 24 - Equities.com - Egalet Corp (EGLT) Drops 5.32% on February 24Equities.comEgalet Corp (EGLT) was one of the Russell 2000's biggest losers for Wednesday February 24 as the stock slid 5.32% to $7.47, a loss of $-0.4199 per share. Starting at an opening price of $7.80 a share, the stock traded between $7.11 and $7.80 over the ...and more »
02/23/16 05:00 AMEgalet to Host Conference Call and Webcast to Discuss Fourth Quarter 2016 Financial Results on March 8, 2016 - [PR Newswire] - WAYNE, Pa., Feb. 23, 2016 /PRNewswire/ -- Egalet Corporation (EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced that its fourth quarter financial results will be released on Tuesday, March 8, 2016. The Company has two approved products: OXAYDO™ (oxycodone HCI, USP) tablets for oral use only –CII and SPRIX® (ketorolac tromethamine) Nasal Spray.
02/14/16 12:35 PMGOP Contenders Prepare to Face Off in SC Debate - Emerald Advisers Inc. PA Increases Position in Egalet Corp (EGLT) Republican presidential candidate Sen. Seventeen made it to a formal announcement. Marco Rubio. Ben Carson is, for all intents and purposes, out of the race. Here is how each of them could ...
02/09/16 01:07 PMEgalet Corporation (NASDAQ:EGLT) Shorted Shares Increased 1.82% After Market Selling - fdanewsalert.com - Egalet Corporation (NASDAQ:EGLT) Shorted Shares Increased 1.82% After Market Sellingfdanewsalert.comThe stock of Egalet Corporation (NASDAQ:EGLT) registered an increase of 1.82% in short interest. EGLT's total short interest was 2.28M shares in February as published by FINRA. Its up 1.82% from 2.24 million shares, reported previously. With 114,000 ...Emerald Advisers Inc. PA Increases Position in Egalet Corp (EGLT)Financial Market NewsCantor Fitzgerald Reaffirms "Buy" Rating for Egalet Corp (EGLT)Daily PoliticalTop Stories: Egalet Corporation (NASDAQ:EGLT), Infosys Limited (NYSE:INFY), Enerplus Corporation (NYSE:ERF ...Stock TranscriptPR Newswire (press release) -WallStreet.orgall 15 news articles »
02/09/16 05:00 AMEgalet to Present at BIO CEO & Investor Conference - [PR Newswire] - WAYNE, Pa., Feb. 9, 2016 /PRNewswire/ -- Egalet Corporation (EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced that Bob Radie, president and chief executive officer, will present at the 18th Annual BIO CEO & Investor Conference in New York. Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. The Company has two approved products: OXAYDO® (oxycodone HCI, USP) tablets for oral use only –CII and SPRIX® (ketorolac tromethamine) Nasal Spray.
02/08/16 01:08 PMEgalet (EGLT) Enters SPRIX Nasal Spray Promotional Agreement with Septodont - Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Egalet Corporation (Nasdaq: EGLT) announced a collaboration agreement with Septodont, Inc., a company dedicated to providing innovative pharmaceutical products to the ...
02/08/16 05:03 AM6:03 am Egalet signs agreement with Septodont to promote SPRIX Nasal Spray to dentists in US -
02/08/16 05:00 AMEgalet Signs Agreement with Septodont, Inc. to Promote SPRIX® (ketorolac tromethamine) Nasal Spray to Dentists in United States - [PR Newswire] - WAYNE, Pa., Feb. 8, 2016 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing ...
02/03/16 12:12 PMPrice Target Update On Egalet Corp (EGLT) - Risers & Fallers - Price Target Update On Egalet Corp (EGLT)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Egalet Corp (EGLT). According to the latest broker reports 3 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, 0 analysts “underperform ...
01/27/16 11:37 AMAnalysts Bullish on Biotech Companies Merrimack Pharmaceuticals Inc (MACK) and Egalet Corp (EGLT) Amid Pipeline ... - Smarter Analyst - Smarter AnalystAnalysts Bullish on Biotech Companies Merrimack Pharmaceuticals Inc (MACK) and Egalet Corp (EGLT) Amid Pipeline ...Smarter AnalystBiotechnology companies are kicking of pipeline trials for 2016. Analysts weigh in on Merrimack Pharmaceuticals Inc (NASDAQ:MACK) and Egalet Corp (NASDAQ:EGLT) in light of the companies' drugs for cancer therapies and opioid addiction, respectively.
01/22/16 06:22 PMEgalet Corp (EGLT) Drops 6.7% on January 21 - Equities.com - Egalet Corp (EGLT) Drops 6.7% on January 21Equities.comEgalet Corp (EGLT) was one of the Russell 2000's biggest losers for Thursday January 21 as the stock slid 6.7% to $8.08, a loss of $-0.58 per share. Starting at an opening price of $8.70 a share, the stock traded between $8.01 and $8.81 over the course ...and more »
01/22/16 06:22 PMEgalet Corp (EGLT) Jumps 5.07% on January 22 - Equities.com - Egalet Corp (EGLT) Jumps 5.07% on January 22Equities.comEgalet Corp (EGLT) was among the biggest gainers on the Russell 2000 for Friday January 22 as the stock popped 5.07% to $8.50, representing a gain of $0.41 per share. Some 40,634 shares traded hands on 429 trades, compared with an average daily ...
01/18/16 06:05 PMEgalet Corp (EGLT) Drops 6.4% on January 18 - Equities.com - Egalet Corp (EGLT) Drops 6.4% on January 18Equities.comEgalet Corp (EGLT) was one of the Russell 2000's biggest losers for Monday January 18 as the stock slid 6.4% to $7.90, a loss of $-0.54 per share. Starting at an opening price of $8.33 a share, the stock traded between $7.60 and $8.78 over the course ...and more »
01/17/16 05:57 PMOversold Conditions For Egalet (EGLT) - A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Egalet Corp (EGLT) entered into oversold territory, hitting an RSI reading of 28.1, after changing hands as low as $8.11 per share. By comparison ...
12/15/15 05:46 AMEgalet Submits New Drug Application to U.S. Food and Drug Administration for ARYMO™ ER (Morphine Sulfate) Extended-Release Tablets - [at noodls] - WAYNE, Pa., Dec. 15, 2015/PRNewswire / -- Egalet Corporation (Nasdaq: EGLT) ('Egalet'), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative ...
12/14/15 03:32 PMEGALET CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -
About Egalet Corp

Egalet Corp logoEgalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company's products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company's product SPRIX Nasal Spray, which contains ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. The Company's product OXAYDO is an approved immediate-release (IR) oxycodone product formulated to deter abuse through snorting. The Company's product candidate, ARYMO ER is an abuse-deterrent (AD), extended-release (ER), oral morphine formulation. The Company's product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EGLT
  • CUSIP:
Key Metrics:
  • Previous Close: $4.75
  • 50 Day Moving Average: $5.38
  • 200 Day Moving Average: $7.37
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $116.17M
  • Current Quarter EPS Consensus Estimate: $-3.12 EPS
Additional Links:
Egalet Corp (NASDAQ:EGLT) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha